Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy
Clinical trial NCT00932282 · COMPLETED
Trial details
- NCT number
- NCT00932282
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2015-08-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.